Araştırma Makalesi
BibTex RIS Kaynak Göster

The Involvement of ATP-Sensitive Potassium Channels in the Nebivolol-Induced Relaxation of Endothelium-Intact Aorta Isolated from Rats

Yıl 2020, Cilt: 6 Sayı: 2, 201 - 206, 31.08.2020
https://doi.org/10.19127/mbsjohs.708294

Öz

Objective: Nebivolol is a highly selective beta-1 adrenergic receptor blocker with additional vasorelaxant properties. The vasorelaxant effect of nebivolol has been mainly attributed to endothelium-dependent mechanisms including beta-adrenergic receptors. However, the involvement of ATP-sensitive potassium (KATP) channels, another potential mechanism for vasorelaxant effect, in the vasorelaxant response to nebivolol remains unclear. Therefore, this study was aimed to investigate the role of KATP channels in the nebivolol-induced vasorelaxation in the isolated rat aorta
Methods: The rat thoracic aortic rings isolated from Sprague-Dawley rats were mounted in organ bath chambers containing Krebs-Henseleit solution at 37 oC continuously bubbled with 95% O2 and 5% CO2. After an equilibration period, the presence of endothelium was confirmed by the response (more than 50%) to acetylcholine (10 μM) in aortic rings precontracted with phenylephrine (1 μM). After washout, in control group, the endothelium-intact aortic rings were contracted by potassium chloride (30 mM) before the cumulative addition of nebivolol (0.0001-100 μM). In some experiments, the relaxant response to nebivolol (0.0001-100 μM) was also obtained in the presence of glibenclamide (KATP channel blocker, 10 μM) or Nω-Nitro-L-arginine methyl ester (L-NAME: eNOS inhibitor, 100 μM) in the endothelium-intact aortic rings precontracted with potassium chloride (30 mM). Data were presented as means±SEM. Multiple comparisons of groups were performed by using ANOVA followed by post-hoc Bonferroni test.
Results: Nebivolol elicited a concentration dependent vasorelaxant effect in the endothelium-intact aortic rings. Relaxant response to nebivolol was significantly inhibited by the presence of glibenclamide or L-NAME (p< 0.05). Although Emax values were not found significantly different among groups, pD2 values of nebivolol were reduced in the endothelium-intact aortic rings incubated with glibenclamide or L-NAME.
Conclusion: These results demonstrate for the first time the involvement of KATP channels in the nebivolol-induced vasorelaxation in the endothelium-intact aorta precontracted with potassium chloride.

Teşekkür

I would like to thank to Zeynep Elif YEŞİLYURT (PhD student at Ankara University Faculty of Pharmacy Department of Pharmacology) for technical support.

Kaynakça

  • Arsyad A, Dobson GP. Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: possible role of Kv, KATP channels and A2a receptor crosstalk. BMC Anesthesiol 2016; 16(1): 121.
  • Ashcroft FM, Puljung MC, Vedovato N. Neonatal Diabetes and the KATP Channel: From Mutation to Therapy. Trends Endocrinol Metab 2017; 28 (5): 377-387.
  • Aziz Q, Li Y, Tinker A. ATP-sensitive potassium channels and vascular function. Channels (Austin) 2015; 9(1): 3-4.
  • Aziz Q, Li Y, Anderson N, Ojake L, Tsisanova E, Tinker A. Molecular and functional characterization of the endothelial ATP-sensitive potassium channel. J Biol Chem 2017; 292(43): 17587-17597.
  • Biaggioni I, Robertson D. Adrenoceptor Agonists & Sympathomimetic Drugs. Katzung, B.G. (ed). Basic & Clinical Pharmacology. USA: McGraw-Hill Education; 2018, p:137-155.
  • Broeders MA, Doevendans PA, Bekkers BC, Bronsaer R, van Gorsel E, Heemskerk JW, et al. Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production. Circulation 2000; 102(6): 677-684.
  • Cicero AFG, Kuwabara M, Borghi C. A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension. Drugs 2018; 78(17): 1783-1790.
  • de Groot AA, Mathy MJ, van Zwieten PA, Peters SL. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta. J Cardiovasc Pharmacol 2003; 42(2): 232-236.
  • Erdei N, Papp Z, Pollesello P, Edes I, Bagi Z. The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles. Br J Pharmacol 2006; 148(5): 696-702.
  • Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006; 91(3): H985-1002
  • Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 1992; 105(2): 429-435.
  • Ito M, Yamamoto I, Naruse A, Suzuki Y, Satake N, Shibata S. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells. J Cardiovasc Pharmacol 1997; 29(2): 232-239.
  • Kuo L, Chancellor JD. Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels in endothelium. Am J Physiol 1995; 269: H541-H549.
  • Mateus LS, Albuquerque AAS, Celotto AC, Evora PRB. In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel. Pharmacol Rep 2019; 71(3): 522-527.
  • Olawi N, Krüger M, Grimm D, Infanger M, Wehland M. Nebivolol in the treatment of arterial hypertension. Basic Clin Pharmacol Toxicol 2019; 125(3): 189-201.
  • Pantan R, Onsa-Ard A, Tocharus J, Wonganan O, Suksamrarn A, Tocharus C. Endothelium-independent vasorelaxation effects of 16-O-acetyldihydroisosteviol on isolated rat thoracic aorta. Life Sci 2014; 116(1):31-36.
  • Pullen C, Coulson FR, Fenning A. Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues From Young Rats. Adv Pharmacol Sci 2014; 2014: 720386.
  • Rautureau Y, Toumaniantz G, Serpillon S, Jourdon P, Trochu JN, Gauthier C. Beta 3-adrenoceptor in Rat Aorta: Molecular and Biochemical Characterization and Signalling Pathway. Br J Pharmacol 2002; 137(2):153-61.
  • Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 2001; 21(1): 28-38
  • Tinker A, Aziz Q, Thomas A. The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system. Br J Pharmacol 2014; 171(1): 12-23.
  • Vanheel B, Van de Voorde J, Leusen I. Contribution of nitric oxide to the endothelium-dependent hyperpolarization in rat aorta. J Physiol. 1994; 475(2): 277-284.
  • Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol (Oxf). 2017; 219(1): 22-96.
  • Wang Y, Zhang M, Liu Y, Li J, Song E, Niu L, Cheng N. Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries. J Cardiovasc Pharmacol Ther 2009; 14(4): 332-338.
Yıl 2020, Cilt: 6 Sayı: 2, 201 - 206, 31.08.2020
https://doi.org/10.19127/mbsjohs.708294

Öz

Kaynakça

  • Arsyad A, Dobson GP. Lidocaine relaxation in isolated rat aortic rings is enhanced by endothelial removal: possible role of Kv, KATP channels and A2a receptor crosstalk. BMC Anesthesiol 2016; 16(1): 121.
  • Ashcroft FM, Puljung MC, Vedovato N. Neonatal Diabetes and the KATP Channel: From Mutation to Therapy. Trends Endocrinol Metab 2017; 28 (5): 377-387.
  • Aziz Q, Li Y, Tinker A. ATP-sensitive potassium channels and vascular function. Channels (Austin) 2015; 9(1): 3-4.
  • Aziz Q, Li Y, Anderson N, Ojake L, Tsisanova E, Tinker A. Molecular and functional characterization of the endothelial ATP-sensitive potassium channel. J Biol Chem 2017; 292(43): 17587-17597.
  • Biaggioni I, Robertson D. Adrenoceptor Agonists & Sympathomimetic Drugs. Katzung, B.G. (ed). Basic & Clinical Pharmacology. USA: McGraw-Hill Education; 2018, p:137-155.
  • Broeders MA, Doevendans PA, Bekkers BC, Bronsaer R, van Gorsel E, Heemskerk JW, et al. Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production. Circulation 2000; 102(6): 677-684.
  • Cicero AFG, Kuwabara M, Borghi C. A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension. Drugs 2018; 78(17): 1783-1790.
  • de Groot AA, Mathy MJ, van Zwieten PA, Peters SL. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta. J Cardiovasc Pharmacol 2003; 42(2): 232-236.
  • Erdei N, Papp Z, Pollesello P, Edes I, Bagi Z. The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles. Br J Pharmacol 2006; 148(5): 696-702.
  • Félétou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 2006; 91(3): H985-1002
  • Garland CJ, McPherson GA. Evidence that nitric oxide does not mediate the hyperpolarization and relaxation to acetylcholine in the rat small mesenteric artery. Br J Pharmacol 1992; 105(2): 429-435.
  • Ito M, Yamamoto I, Naruse A, Suzuki Y, Satake N, Shibata S. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells. J Cardiovasc Pharmacol 1997; 29(2): 232-239.
  • Kuo L, Chancellor JD. Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels in endothelium. Am J Physiol 1995; 269: H541-H549.
  • Mateus LS, Albuquerque AAS, Celotto AC, Evora PRB. In vitro evidence that endothelium-dependent vasodilatation induced by clozapine is mediated by an ATP-sensitive potassium channel. Pharmacol Rep 2019; 71(3): 522-527.
  • Olawi N, Krüger M, Grimm D, Infanger M, Wehland M. Nebivolol in the treatment of arterial hypertension. Basic Clin Pharmacol Toxicol 2019; 125(3): 189-201.
  • Pantan R, Onsa-Ard A, Tocharus J, Wonganan O, Suksamrarn A, Tocharus C. Endothelium-independent vasorelaxation effects of 16-O-acetyldihydroisosteviol on isolated rat thoracic aorta. Life Sci 2014; 116(1):31-36.
  • Pullen C, Coulson FR, Fenning A. Effects of Resveratrol and Nebivolol on Isolated Vascular and Cardiac Tissues From Young Rats. Adv Pharmacol Sci 2014; 2014: 720386.
  • Rautureau Y, Toumaniantz G, Serpillon S, Jourdon P, Trochu JN, Gauthier C. Beta 3-adrenoceptor in Rat Aorta: Molecular and Biochemical Characterization and Signalling Pathway. Br J Pharmacol 2002; 137(2):153-61.
  • Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol 2001; 21(1): 28-38
  • Tinker A, Aziz Q, Thomas A. The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system. Br J Pharmacol 2014; 171(1): 12-23.
  • Vanheel B, Van de Voorde J, Leusen I. Contribution of nitric oxide to the endothelium-dependent hyperpolarization in rat aorta. J Physiol. 1994; 475(2): 277-284.
  • Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol (Oxf). 2017; 219(1): 22-96.
  • Wang Y, Zhang M, Liu Y, Li J, Song E, Niu L, Cheng N. Neither K+ channels nor PI3K/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries. J Cardiovasc Pharmacol Ther 2009; 14(4): 332-338.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Olgu Sunumu
Yazarlar

Hande Ozge Altunkaynak-camca 0000-0002-4547-7756

Yayımlanma Tarihi 31 Ağustos 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 6 Sayı: 2

Kaynak Göster

Vancouver Altunkaynak-camca HO. The Involvement of ATP-Sensitive Potassium Channels in the Nebivolol-Induced Relaxation of Endothelium-Intact Aorta Isolated from Rats. Mid Blac Sea J Health Sci. 2020;6(2):201-6.

2310022108  22107  22106  22105  22103  22109 22137 22102  22110    e-ISSN 2149-7796